(NT-proBNP) increase in response to volume overload and help in the differential diagnosis of acute heart failure. Elevated plasma BNP levels are observed also in sepsis and do not always correspond to left ventricular dysfunction. Here, we investigated plasma NT-proBNP fluctuations in response to human bacterial endotoxinemia, an experimental model of systemic infection and inflammation. Escherichia coli endotoxin (LPS) (2 ng/kg) was administered to 10 healthy volunteers in a randomized, placebo-controlled, cross-over design. Plasma NTproBNP, C-reactive protein (CRP), COOH terminal pro-endothelin-1 (CT-proET-1), and midregional-pro-adrenomedullin (MR-proADM) were measured at hourly intervals for 6 h. LPS administration induced a continuous increase in plasma NT-proBNP that reached peak values after 6 h (40.7 Ϯ 7.9 vs. 16.1 Ϯ 3.2 pg/ml in placebo days, mean Ϯ SE; P ϭ 0.023). The profile of changes in NT-proBNP correlated to changes in body temperature (P Ͻ 0.001), heart rate (P ϭ 0.005), CRP (P Ͻ 0.001), and CT-proET-1 (P ϭ 0.008), but not to blood pressure values. Our results demonstrate that plasma NT-proBNP increases in a model of systemic infection/inflammation in healthy men with normal heart function. This finding emphasizes the necessity to consider concomitant infections when interpreting elevated circulating NT-proBNP concentrations.B-type natriuretic peptide; C-reactive protein; bacterial endotoxin; infection; inflammation; human B-TYPE NATRIURETIC PEPTIDE (BNP) is secreted from atria and ventricles in response to volume load and myocardial wall stress (6, 24). It promotes vasodilatation, natriuresis, and diuresis (6). In the circulation, the prohormone is cleaved into two peptides: the physiologically active BNP and the inactive NH 2 -terminal-proBNP (NT-proBNP) (1). NT-proBNP has higher plasma levels and a longer half-life and therefore slower fluctuations (6). BNP and NT-proBNP are both helpful in the diagnosis of cardiac dysfunction and heart failure (16, 29) and equivalent in the prognosis of ischemic heart disease (21). Even modest elevations of the peptides are associated with increased risk of cardiovascular events, heart failure, stroke, and all-cause mortality (2, 34).BNP and NT-proBNP plasma levels depend on age and gender, are altered in the presence of renal disease and obesity (6), and are elevated in sepsis (3, 4). NT-proBNP correlates to the Acute Physiology and Chronic Health Evaluation scores and is found to be a prognostic marker in sepsis and septic shock (3, 4). Elevated BNP levels in sepsis might be attributed to the underlying myocardial dysfunction (32). Nevertheless, BNP is elevated also in septic patients with neither clinical nor echocardiographic evidence of left ventricular systolic dysfunction (26). Moreover, increased plasma BNP is found also in patients with infections in the absence of severe sepsis or septic shock (18). The existence of a direct association between infections and BNP is supported by evidence from preclinical studies, since LPS and pro-inflammatory c...